How severe is CVE-2025-61885?

CVE-2025-61885 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.

Is CVE-2025-61885 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (12th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2025-61885?

CVE-2025-61885 affects Oracle Life Sciences Inform. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2025-61885?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2025-61885 have an EU (EUVD) identifier?

Yes. CVE-2025-61885 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-35244.

When was CVE-2025-61885 published?

CVE-2025-61885 was published on 2025-10-21 and last updated on 2026-06-17.

CVE-2025-61885

CVE-2025-61885 is a medium-severity vulnerability in Oracle Life Sciences Inform with a CVSS 3.x base score of 4.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-200.

Key facts

Severity: Medium (CVSS 3.x base score 4.3)
EPSS exploit prediction: 0% (12th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-35244
Weakness: CWE-200
Affected product: Oracle Life Sciences Inform
Published: 2025-10-21
Last modified: 2026-06-17

Description

Vulnerability in the Oracle Life Sciences InForm product of Oracle Health Sciences Applications (component: Web Server). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).

Frequently asked questions

What is CVE-2025-61885?: Vulnerability in the Oracle Life Sciences InForm product of Oracle Health Sciences Applications (component: Web Server). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
How severe is CVE-2025-61885?: CVE-2025-61885 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2025-61885 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (12th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-61885?: CVE-2025-61885 affects Oracle Life Sciences Inform. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-61885?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-61885 have an EU (EUVD) identifier?: Yes. CVE-2025-61885 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-35244.
When was CVE-2025-61885 published?: CVE-2025-61885 was published on 2025-10-21 and last updated on 2026-06-17.

References

https://www.oracle.com/security-alerts/cpuoct2025.html

Affected products (1)

cpe:2.3:a:oracle:life_sciences_inform:7.0.1.0:*:*:*:*:*:*:*

More vulnerabilities in Oracle Life Sciences Inform

CVE-2026-34324 — Medium (CVSS 6.5): Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server).…
CVE-2026-34323 — Medium (CVSS 6.3): Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM…
CVE-2025-62287 — Medium (CVSS 6.1): Vulnerability in the Oracle Life Sciences InForm product of Oracle Health Sciences Applications (component: Web…

All CVEs affecting Oracle Life Sciences Inform →

Other CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities

CVE-2026-27604 — Critical (CVSS 10.0): FOSSBilling is a free, open-source billing and client management system. Starting in version 0.5.4 and prior to version…
CVE-2026-40965 — Critical (CVSS 10.0): Cloud Foundry UAA versions v76.12.0 through v78.12.0 are vulnerable to a private key exposure. The server contains a…
CVE-2026-42826 — Critical (CVSS 10.0): Exposure of sensitive information to an unauthorized actor in Azure DevOps allows an unauthorized attacker to disclose…
CVE-2025-29270 — Critical (CVSS 10.0): Incorrect access control in the realtime.cgi endpoint of Deep Sea Electronics devices DSE855 v1.1.0 to v1.1.26 allows…
CVE-2025-61481 — Critical (CVSS 10.0): An issue in MikroTik RouterOS v.7.14.2 and SwOS v.2.18 exposes the WebFig management interface over cleartext HTTP by…
CVE-2025-53624 — Critical (CVSS 10.0): The Docusaurus gists plugin adds a page to your Docusaurus instance, displaying all public gists of a GitHub user.…

Browse all CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities →